BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15162063)

  • 21. Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome.
    Stams WA; Beverloo HB; den Boer ML; de Menezes RX; Stigter RL; van Drunen E; Ramakers-van-Woerden NL; Loonen AH; van Wering ER; Janka-Schaub GE; Pieters R
    Leukemia; 2006 Mar; 20(3):410-6. PubMed ID: 16424874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between the ETV6/CBFA2 (TEL/AML1) fusion gene and karyotypic abnormalities in children with B-cell precursor acute lymphoblastic leukemia.
    Fears S; Vignon C; Bohlander SK; Smith S; Rowley JD; Nucifora G
    Genes Chromosomes Cancer; 1996 Oct; 17(2):127-35. PubMed ID: 8913730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RUNX1 aberrations in ETV6/RUNX1-positive and ETV6/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALL.
    Pais AP; Amare Kadam PS; Raje GC; Banavali S; Parikh P; Kurkure P; Arora B; Gujral S; Kumar SA; Badrinath Y
    Pediatr Hematol Oncol; 2008 Sep; 25(6):582-97. PubMed ID: 18728978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TEL-AML1 fusion in acute lymphoblastic leukemia with L3 morphology.
    Abdelhaleem M; Shago M; Abla O
    Pediatr Blood Cancer; 2007 Aug; 49(2):217. PubMed ID: 16826562
    [No Abstract]   [Full Text] [Related]  

  • 25. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
    Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
    Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemia.
    von Goessel H; Jacobs U; Semper S; Krumbholz M; Langer T; Keller T; Schrauder A; van der Velden VH; van Dongen JJ; Harbott J; Panzer-Grümayer ER; Schrappe M; Rascher W; Metzler M
    Leuk Res; 2009 Aug; 33(8):1082-8. PubMed ID: 19081626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
    Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow cytometry.
    Alm SJ; Engvall C; Asp J; Palmqvist L; Abrahamsson J; Fogelstrand L
    Int J Lab Hematol; 2017 Apr; 39(2):121-128. PubMed ID: 28004528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol.
    Barbany G; Andersen MK; Autio K; Borgström G; Franco LC; Golovleva I; Heim S; Heinonen K; Hovland R; Johansson B; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E; ; ;
    Leuk Res; 2012 Jul; 36(7):936-8. PubMed ID: 22521551
    [No Abstract]   [Full Text] [Related]  

  • 30. ETV6/RUNX1 fusion lacking prognostic effect in pediatric patients with acute lymphoblastic leukemia.
    Zen PR; Capra ME; Silla LM; Loss JF; Fernandes MS; Jacques SM; Paskulin GA
    Cancer Genet Cytogenet; 2009 Jan; 188(2):112-7. PubMed ID: 19100516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interphase-FISH screening for eight common rearrangements in pediatric B-cell precursor acute lymphoblastic leukemia.
    Hutspardol S; Pakakasama S; Kanta K; Nuntakarn L; Anurathapan U; Sirachainan N; Songdej D; Sawangpanich R; Tiyasirichokchai R; Rerkamnuaychoke B; Hongeng S
    Int J Lab Hematol; 2013 Aug; 35(4):406-15. PubMed ID: 23190578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-induction residual disease in translocation t(12;21)-positive childhood ALL.
    Seyfarth J; Madsen HO; Nyvold C; Ryder LP; Clausen N; Jonmundsson GK; Wesenberg F; Schmiegelow K
    Med Pediatr Oncol; 2003 Feb; 40(2):82-7. PubMed ID: 12461790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
    Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
    Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A unique variant of ETV6/AML1 fusion in a child with acute lymphoblastic leukemia.
    Jalali GR; Martineau M; Ford AM; Greaves M; Stevens RF; Harrison CJ
    Leukemia; 2003 May; 17(5):993-5. PubMed ID: 12750722
    [No Abstract]   [Full Text] [Related]  

  • 35. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
    Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
    Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ETV6/RUNX1 rearrangement in childhood B-precursor acute lymphoblastic leukemia with normal karyotypes or without cytogenetic results.
    Alvarez Y; Gaitán S; Perez A; Bastida P; Ortega JJ; Dastugue N; Robert A; Aventín A; Badell I; Guitart M; Melo M; Caballín MR; Coll MD
    Cancer Genet Cytogenet; 2004 Jul; 152(1):77-80. PubMed ID: 15193447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning and sequencing of ETV6/RUNX1 (TEL/AML1) variant in acute lymphoblastic leukemia.
    Tiensiwakul P
    Cancer Genet Cytogenet; 2004 Feb; 149(1):85-8. PubMed ID: 15104290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The presence of TEL/AML1 rearrangement and cryptic deletion of the TEL gene in adult acute lymphoblastic leukemia (ALL).
    Lee DS; Kim YR; Cho HK; Lee CK; Lee JH; Cho HI
    Cancer Genet Cytogenet; 2005 Oct; 162(2):176-8. PubMed ID: 16213368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia.
    Al-Shehhi H; Konn ZJ; Schwab CJ; Erhorn A; Barber KE; Wright SL; Gabriel AS; Harrison CJ; Moorman AV
    Genes Chromosomes Cancer; 2013 Feb; 52(2):202-13. PubMed ID: 23077088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification.
    De Zen L; Orfao A; Cazzaniga G; Masiero L; Cocito MG; Spinelli M; Rivolta A; Biondi A; Zanesco L; Basso G
    Leukemia; 2000 Jul; 14(7):1225-31. PubMed ID: 10914546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.